{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "esgPopulated": false, "market": "dr_market", "longName": "Cybin Inc.", "marketState": "REGULAR", "regularMarketPrice": 0.274, "messageBoardId": "finmb_666815486", "exchange": "FRA", "shortName": "CYBIN INC.", "exchangeTimezoneShortName": "CEST", "exchangeTimezoneName": "Europe/Berlin", "regularMarketChangePercent": -2.8368852, "gmtOffSetMilliseconds": 7200000, "fiftyTwoWeekLowChange": 0.032099992, "fiftyTwoWeekLowChangePercent": 0.13269943, "fiftyTwoWeekRange": "0.2419 - 1.12", "fiftyTwoWeekHighChange": -0.846, "fiftyTwoWeekHighChangePercent": -0.75535715, "fiftyTwoWeekLow": 0.2419, "fiftyTwoWeekHigh": 1.12, "earningsTimestamp": 1644526800, "earningsTimestampStart": 1644526800, "earningsTimestampEnd": 1644526800, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.2, "epsForward": -0.26, "firstTradeDateMilliseconds": 1608102000000, "priceHint": 4, "regularMarketChange": -0.008000016, "regularMarketTime": 1683892036, "regularMarketDayHigh": 0.274, "regularMarketDayRange": "0.272 - 0.274", "regularMarketDayLow": 0.272, "regularMarketVolume": 1000, "regularMarketPreviousClose": 0.282, "bid": 0.276, "ask": 0.29, "fullExchangeName": "Frankfurt", "financialCurrency": "CAD", "regularMarketOpen": 0.274, "averageDailyVolume3Month": 276, "averageDailyVolume10Day": 100, "sharesOutstanding": 189220000, "bookValue": 0.295, "fiftyDayAverage": 0.344846, "fiftyDayAverageChange": -0.07084602, "fiftyDayAverageChangePercent": -0.20544249, "twoHundredDayAverage": 0.4756475, "twoHundredDayAverageChange": -0.20164752, "twoHundredDayAverageChangePercent": -0.4239432, "marketCap": 53123664, "forwardPE": -1.0538461, "priceToBook": 0.9288136, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Cybin, Inc.", "nameChangeDate": "2023-05-11", "averageAnalystRating": "1.3 - Strong Buy", "tradeable": false, "cryptoTradeable": false, "symbol": "R7E1.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "100 King Street West", "address2": "Suite 5600", "city": "Toronto", "state": "ON", "zip": "M5X 1C9", "country": "Canada", "website": "https://www.cybin.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.", "fullTimeEmployees": 50, "companyOfficers": [{"maxAge": 1, "name": "Mr. Eric  So L.L.B., LLB", "age": 46, "title": "Co-Founder, Pres & Exec. Chairman", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 470862, "fmt": "470.86k", "longFmt": "470,862"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Douglas L. Drysdale", "age": 52, "title": "Chief Exec. Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": {"raw": 522671, "fmt": "522.67k", "longFmt": "522,671"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Paul  Glavine", "age": 33, "title": "Co-Founder, Chief Growth Officer & Director", "yearBorn": 1989, "fiscalYear": 2022, "totalPay": {"raw": 470862, "fmt": "470.86k", "longFmt": "470,862"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. John  Kanakis", "age": 42, "title": "Co-Founder", "yearBorn": 1980, "fiscalYear": 2022, "totalPay": {"raw": 715530, "fmt": "715.53k", "longFmt": "715,530"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Greg  Cavers", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2022, "totalPay": {"raw": 199219, "fmt": "199.22k", "longFmt": "199,219"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aaron  Bartlone", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Alex L. Nivorozhkin Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Leah  Gibson", "title": "VP of Investor Relations & Strategic Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Lori  Challenger", "title": "Chief Compliance, Ethics & Admin. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Gabriel  Fahel", "age": 46, "title": "Chief Legal Officer & Corp. Sec.", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}